EU PHARMA FORUM

Welcome and introductions of the Event   

08:30 – 09:00

Registration

09:00 – 09:05

Welcome and introduction of the Event

Antonija Mandić, moderator

09:05 – 09:10

Opening Remarks

• Welcome and introduction of participants
• Overview of the event and topics

Ana Soldo, President of Croatian Chamber of Pharmacists

Session 1 – The future of the European Health Union

09:10 – 09:20

Single European market for medicines

• Reform of EU Pharmaceutical Legislation: How will the Pharma Package impact the European and Croatian healthcare systems and patients?

Keynote speaker: Tomislav Sokol, Member of the European Parliament

• HALMED’s role in the context of the new pharmaceutical regulatory framework

Keynote speaker: Siniša Tomić, Head of Agency for Medicinal Products and Medical Devices of Croatia, HALMED

09:25 – 09:30

Aspirations of EU legislative initiatives on medicines

• JAZMP’s role in the context of the new pharmaceutical regulatory framework

Keynote speaker: Momir Radulović, Executive Director of Agency for Medicinal Products and Medical Devices of the Republic of Slovenia, JAZMP

09:40 – 09:50

Regulatory Data Protection and Proposal for a new incentive’s framework

Keynote speaker: Roberta Savli, Executive Director of Public Affairs, EFPIA 

09:50 – 10:30

Panel discussion: “Ensuring the availability of medicines while supporting the competitiveness of the EU’s pharmaceutical industry”

• Discussion on the EU’s proposal to shorten regulatory data protection and orphan market exclusivity baseline for innovative pharmaceuticals
• Will the incentive package be sufficiently attractive for the innovative industry?
• Will the reform ensure improved access to innovative medicines for all EU member states?
• Can the new legislation bring back research and development of new medicines to the EU?
• Implications & analysis

Panel participants: 

• Roberta Savli, Executive Director of Public Affairs, EFPIA
• Ana Soldo, President of Croatian Chamber of Pharmacists 
  
• Tomislav Sokol, Member of EU Parliament
• Goranka Marušić Kontent, Advisor for European Affairs, HALMED
• Yordan Aleksandrov, Senior Manager EU Government Affairs, Pfizer
• Adrian van den Hoven, General Director of Medicines for Europe

10:30 – 10:45 COFFEE BREAK

Session 3 – The Role of Legislations on Investment for Innovation

10:45 – 10:55

The Role of Legislations on Investment for Innovation – Introduction into discussion

Keynote speaker: dr. Claus Runge, Chief Health Equity Officer SVP, Global Head of Public Affairs, Sustainability & Int. Engagement, Bayer

10:55 – 11:35

Panel discussion: “Challenges and opportunities in drugs availability”

• Access and affordability of drugs across all 27 Member states
• What approaches can be taken to make the EU a more appealing destination for investment in innovation?
• What are some examples from EU countries that have successfully accelerated patient access to innovative products?
• What strategies can the EU implement to strengthen its economic resilience against current geopolitical shocks?

Panel participants:

• Ana Soldo, President of Croatian Chamber of Pharmacists

• Claus Runge, Chief Health Equity Officer SVP, Global Head of Public Affairs, Sustainability & Int. Engagement, Bayer
• Tea Strbad, Assistant for medical affairs in Croatian Health Insurance Fund, HZZO

• Nikolina Dizdar – Čehulić, Chief Financial Officer, Pliva/Teva
• Mislav Vučić, Chief Executive Officer, Jadran-Galenic Laboratory, Croatian Employers’ Association – Pharmaceutical Industry Association, HUP

Session 4 – The Role of Generic and Biosimilar Medicines in Enhancing Access

11:35 – 11:45

The Role of Generic and Biosimilar Medicines in Enhancing Access – Introduction into discussion

Keynote speaker: Adrian van den Hoven, Director General Medicines for Europe

11:45 – 12:25

Panel discussion: Will the EU pharmaceutical legislation reform lower the price of the medicines in the EU and ensure new drugs are more accessible?

• Analysis of the patent expiration gap and generic availability
• Discussion on improving access to medications
• Bridging the gap: Ensuring equitable access to medicines across the EU
• The Role of Generic and Biosimilar Medicines in Enhancing Access

Panel participants: 

• Roberta Savli, Executive Director of Public Affairs, EFPIA
• Adrian van den Hoven, Director General for Medicines for Europe
• Ana Gongola, Croatian Employers’ Association – Pharmaceutical Industry Association, HUP. Member of the Management Board of Sandoz Croatia, and Director of Commercial Operations, Lek Slovenia
• Eva Šintić, Acting Head of Department for Utilisation and Prices of Medicines, HALMED
• Jelena Matuzović, Head of Medicine Service in Croatian Health Insurance Fund, HZZO

12:25 – 13:05  LUNCH BREAK

Session 5 – Financial aspect of the reform

13:05 – 13:15

Impact of the Pharma Package on healthcare financing

Keynote speaker: Yannis Natsis, Director of the European Social Insurance Platform, ESIP

13:15 – 13:55

Panel discussion: How will the EU legislative reform impact healthcare financing and the health market supply chain?

• How will the reform affect healthcare system financing? Will services become more expensive?
• Who will bear the financial burden of a potential price increase?
• Impact of the Pharma Package on the health care market supply chain
• Medicine shortages

Panel participants:

• Jorge Batista, Senior Professional Affairs Advisor of the European Community Pharmacists (PGEU)
• Yannis Natsis, Director of the European Social Insurance Platform, ESIP
• Tea Strbad, Assistant for medical affairs in Croatian Health Insurance Fund, HZZO
• Ana Soldo, President of Croatian Chamber of Pharmacists
• Ivan Bumber, Policy & Public Affairs Lead ASB-HUB, Easter Europe, Pfizer

Session 6 – Challenges in health market supply chain

13:55 – 14:05

Challenges in health market supply chain – Introduction into session

Keynote speaker: Margriet Keijzer, Secretary General of Affordable Medicines Europe

14:05 – 14:45

Panel discussion: The EU response to the health market supply chain

• Can the EU respond to all challenges in the potential new health crisis
• Resilience and cohesion of the EU health market
• Towards a unified future: Strengthening health systems in Europe
• Role of health insurance in the formation of a single European health market in the medicines’ availability

Panel participants:

• Ana Kontek, Head of Department for Availability of Medicines, HALMED
• Diana Percač, President of Association of Wholesale Trade of Pharmaceutical and Orthopedic Products, Trade Department, Croatian Chamber of Economy
• Yannis Natsis, Director of the Europen Social Insurance Platform, ESIP
• Margriet Keijzer, Secretary General of Affordable Medicines Europe 
• Tea Strbad, Assistant for medical affairs in Croatian Health Insurance Fund, HZZO

Session 7 – Closing Remarks and Q&A

14:45 – 15:00

Closing remarks: Ana Soldo, President of Croatian Chamber of Pharmacists

• Summary of key points discussed
• Next steps and action items
• Q&A session